Health Canada authorizes vaccine clinical trial for Ebola disease caused by the Bundibugyo virus
Imported from official source
On July 30, 2026, Health Canada authorized Moderna to move forward with a Phase I clinical trial for its candidate mRNA vaccine for Ebola disease caused by the Bundibugyo virus.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
b946a0555ef6cdbcb2380add050441c2- All versions
- Revision history